Recent Blog Posts

View Post: Cancer and Fertility Preservation PDF Guide - Amertha: The Water ...
19 Nov 2009 by m4d35  
The most severe damage comes from radiation to the ovaries or testicles and cancer drugs in the “alkylating agent” category such as cyclophos- phamide, mechlorethamine, chlorambucil, and melphalan. Although sperm production may recover, ... and/or the supply is limited from the frozen sample, the sperm can be used for in vitro fertilization (IVF) and intra- cytoplasmic sperm injection (ICSI). • Women. If time and circumstances allow, women may be treated with IVF. ...
View Blog: Amertha: The Water of Life - http://www.amertha.co.cc/

---

View Post: Stem Cell Transplantation Clinical Trial: Mismatched ...
5 Nov 2009
If you are found to be eligible to take part in this study, you will receive chemotherapy for 6 days: - You will receive melphalan by vein over 30 minutes on Day -8 (8 days before the transplant). ... Starting on Day 7, you will receive filgrastim (G-CSF) once a day as an injection under the skin, until your blood cell counts reach a high enough level. Depending on the type of disease that you have, your doctor may decide to give you rituximab by vein over several hours ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: VELCADE* for multiple myeloma receives front-line approval in Canada
8 Sep 2008
Toronto, Ontario (September 8, 2008) – VELCADE* (bortezomib) for Injection has received Health Canada approval for front-line (first) treatment of multiple myeloma, a fatal blood cancer. ... VELCADE's front-line approval is based on the phase III VISTA (VELCADE as Initial Standard Therapy in Multiple Myeloma: Assessment with Melphalan and Prednisone) trial, recently published in the New England Journal of Medicine (NEJM)1. VISTA is a randomized, international, ...
View Blog: Johnson & Johnson-All News - http://www.jnj.com/connect/news/all/

---

View Post: fda accepts cydex pharmaceuticals' ind application for oncology drug
3 Aug 2009 by admin  
alkeran is packaged as two separate vials that must be combined prior to injection and, due to its limited stability, administered immediately thereafter. cydex's version of melphalan is enabled by captisol®, the company's proprietary ...
View Blog: Discuss Cancer - http://discuss-cancer.com/

---

View Post: melphalan (alkeran)
14 Apr 2008 by admin  
alkeran pills and injection include the fighting ingredient melphalan, which is a type of chemotherapy medicine to treat cancer named an alkylating agent. cancers form when some cells amongst the body multiply uncontrollably and ...
View Blog: Teen Cancer - http://www.teencancer.com/

---

View Post: FDA Grants Priority Review Status to Supplement Containing Long ...
18 Sep 2009 by Calisha Myers  
Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onset is 70 years), recent statistics indicate both increasing incidence and younger ...
View Blog: Press Releases - http://www.fiercebiotech.com/press-releases

---

View Post: FDA Approves Millennium Pharmaceuticals, Inc. (Cambridge ...
23 Jun 2008
Patients were randomized to receive either nine 6 week cycles of oral melphalan (M) plus prednisone (P) or MP plus VELCADE. Patients received M (9 mg/m2) plus P (60 mg/m2) daily for four days every 6 weeks or the same MP schedule with bortezomib ... with previously treated multiple myeloma (N=1008, not including the Phase III, VELCADE plus DOXIL® [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) were integrated and tabulated. ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: melphalan facts and comparsions
10 Nov 2007 by Adrian Hu  
generic name: melphalan injection (mehl-fuh-lan). brand name: alkeran. melphalan should only be used under the supervision of a doctor experienced with the use of cancer medicines. melphalan may cause a decrease in the body's blood ...
View Blog: longhillbio - http://www.longhillbio.com/blog/Newsen.html

---

View Post: Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection ...
21 Dec 2007
The VISTA trial compared VELCADE melphalan and prednisone (VcMP) tot... This submission is an important step in expanding the benefits ofVEL...,Millennium,Submits,sNDA,for,VELCADE(R),(Bortezomib),for,Injection,for,the,Treatment,of,Front- Line,Multiple,Myeloma ... with melphalan and prednisone. About Multiple Myeloma. Multiple myeloma is the second most common hematologic malignancy and although the disease is predominantly a cancer of the elderly (the median age of onse ...
View Blog: Latest Medical News from Bio-Medicine.Org - http://www.bio-medicine.org/medicine-news-1/

---

View Post: multiple myeloma
28 Jul 2009 by jana  
doxil (doxorubicin liposome injection) is a new way of delivering chemotherapy. myeloma represents a new treatment paradigm (a set of assumptions and practices) in cancer because the new drugs that target the tumor cell, ...
View Blog: People Living with Cancer - http://plwc.org.za/

---